| Genetic and phenotypic attributes of splenic marginal zone lymphoma F Bonfiglio, A Bruscaggin, F Guidetti, L Terzi di Bergamo, M Faderl, ... Blood, The Journal of the American Society of Hematology 139 (5), 732-747, 2022 | 56 | 2022 |
| Microglial overexpression of fALS-linked mutant SOD1 induces SOD1 processing impairment, activation and neurotoxicity and is counteracted by the autophagy inducer trehalose F Massenzio, E Peña-Altamira, S Petralla, M Virgili, G Zuccheri, A Miti, ... Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1864 (12 …, 2018 | 35 | 2018 |
| Epithelial growth factor receptor expression influences 5-ALA induced glioblastoma fluorescence AO Fontana, D Piffaretti, F Marchi, F Burgio, AB Faia-Torres, P Paganetti, ... Journal of Neuro-oncology 133, 497-507, 2017 | 24 | 2017 |
| Protoporphyrin IX tracer fluorescence modulation for improved brain tumor cell lines visualization D Piffaretti, F Burgio, M Thelen, A Kaelin-Lang, P Paganetti, M Reinert, ... Journal of Photochemistry and Photobiology B: Biology 201, 111640, 2019 | 19 | 2019 |
| Quantitative modulation of PpIX fluorescence and improved glioma visualization M Reinert, D Piffaretti, M Wilzbach, C Hauger, R Guckler, F Marchi, ... Frontiers in surgery 6, 41, 2019 | 16 | 2019 |
| Tuning the surface chemistry of gold nanoparticles to specifically image glioblastoma cells using surface-enhanced Raman spectroscopy F Burgio, D Piffaretti, F Schmidt, U Pieles, M Reinert, MF Ritz, S Saxer ACS Applied Nano Materials 3 (3), 2447-2454, 2020 | 5 | 2020 |
| Ibrutinib dose intensity in high‐risk chronic lymphocytic leukemia G Forestieri, L Terzi di Bergamo, M Deodato, AM Frustaci, R Moia, ... Hematological Oncology 40 (5), 1100-1104, 2022 | 2 | 2022 |
| Corrigendum to" Protoporphyrin IX tracer fluorescence modulation for improved brain tumor cell lines visualization" D Piffaretti, F Burgio, M Thelen, A Kaelin-Lang, P Paganetti, M Reinert, ... Journal of Photochemistry and Photobiology B: Biology 205, 111828, 2020 | 2 | 2020 |
| Clinical utility of circulating tumor DNA qualification and quantification in classical Hodgkin lymphoma MC Pirosa, A Bruscaggin, L Terzi Di Bergamo, M Salehi, V Spina, K Pini, ... Hematological Oncology 41, 319-321, 2023 | 1 | 2023 |
| S225: CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER AT BASELINE AND IMPROVES THE ACCURACY OF INTERIM PET IN CLASSIC HODGKIN LYMPHOMA MC Pirosa, A Bruscaggin, LT di Bergamo, M Salehi, K Pini, V Spina, ... HemaSphere 6, 126-127, 2022 | 1 | 2022 |
| CLL-358: Adaptation of Chronic Lymphocytic Leukemia to Ibrutinib Is Mediated by Epigenetic Plasticity of Residual Disease and Bypass Signaling via the MAPK Pathway LT di Bergamo, G Forestieri, JW Loh, A Singh, V Spina, A Zucchetto, ... Clinical Lymphoma Myeloma and Leukemia 21, S323-S324, 2021 | 1 | 2021 |
| Corrigendum: Quantitative modulation of PpIX fluorescence and improved glioma visualization M Reinert, D Piffaretti, M Wilzbach, C Hauger, R Guckler, F Marchi, ... Frontiers in surgery 7, 14, 2020 | 1 | 2020 |
| Discovery Science highlights from the 17th International Conference on Malignant Lymphoma G Forestieri, JM de Almeida, S Napoli, D Piffaretti, C Tarantelli, F Zhang, ... Hematological Oncology 42 (3), e3275, 2024 | | 2024 |
| HL-370 Fragmentóme Profiling Reveals Distinct Molecular Subgroups of Classic Hodgkin Lymphoma LT di Bergamo, MC Pirosa, A Bruscaggin, M Salehi, V Spina, K Pini, ... Clinical Lymphoma Myeloma and Leukemia 22, S348-S349, 2022 | | 2022 |
| Poster: HL-370 Fragmentome Profiling Reveals Distinct Molecular Subgroups of Classic Hodgkin Lymphoma LT di Bergamo, MC Pirosa, A Bruscaggin, M Salehi, V Spina, K Pini, ... Clinical Lymphoma, Myeloma and Leukemia 22, S162, 2022 | | 2022 |
| Poster: CLL-358: Adaptation of Chronic Lymphocytic Leukemia to Ibrutinib Is Mediated by Epigenetic Plasticity of Residual Disease and Bypass Signaling via the MAPK Pathway LT di Bergamo, G Forestieri, JW Loh, A Singh, V Spina, A Zucchetto, ... Clinical Lymphoma Myeloma and Leukemia 21, S221, 2021 | | 2021 |
| CIRCULATING TUMOR DNA IS A PROGNOSTIC BIOMARKER IN CLASSIC HODGKIN LYMPHOMA V Spina, MC Pirosa, A Bruscaggin, A Condoluci, K Pini, G Forestieri, ... Hematological Oncology 39, 2021 | | 2021 |
| IBRUTINIB TOLERABILITY AND OUTCOME IN PATIENTS WITH HIGH‐RISK CHRONIC LYMPHOCYTIC LEUKEMIA A Condoluci, L Terzi‐di‐Bergamo, G Forestieri, R Moia, C Deambrogi, ... Hematological Oncology 39, 2021 | | 2021 |
| ADAPTATION OF CHRONIC LYMPHOCYTIC LEUKEMIA TO IBRUTINIB IS MEDIATED BY EPIGENETIC PLASTICITY OF RESIDUAL DISEASE AND BY‐PASS SIGNALING VIA MAPK PATHWAY L Terzi di Bergamo, G Forestieri, JW Loh, A Singh, V Spina, A Zucchetto, ... Hematological Oncology 39, 2021 | | 2021 |
| CSIG-20. EFFECT OF TUMOR-TREATING FIELDS (TTFIELDS) ON EGFR PHOSPHORYLATION IN GBM CELL LINES ML D’Angelo, D Piffaretti, F Burgio, A Chiappini, F Marchi, M Reinert Neuro-Oncology 21 (Suppl 6), vi48, 2019 | | 2019 |
